Generex Biotechnology Corporation to Make Convertible Debenture Payment in Cash

WORCESTER, Mass., Nov. 12, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (http://www.generex.com) announced today that it intends to make the next payment, due on December 1, 2008, under its Senior Secured Convertible Notes in cash. The aggregate amount of that payment will be $1,376,666.66.

MORE ON THIS TOPIC